These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22795639)

  • 21. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
    Lotke PS
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
    Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
    Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the use of effective and long-acting reversible contraception in Vietnam.
    Asad S; Hebert C; Andridge R; Nguyen N; Gallo MF
    Contraception; 2019 Mar; 99(3):165-169. PubMed ID: 30503505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
    Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
    Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in contraception and sterilization in Australia.
    Santow G
    Aust N Z J Obstet Gynaecol; 1991 Aug; 31(3):201-8. PubMed ID: 1804078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraceptive failure in China.
    Wang D
    Contraception; 2002 Sep; 66(3):173-8. PubMed ID: 12384206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current challenges in contraception in adolescents and young women.
    Cornet A
    Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women's Awareness of, Interest in, and Experiences with Long-acting Reversible and Permanent Contraception.
    Burns B; Grindlay K; Dennis A
    Womens Health Issues; 2015; 25(3):224-31. PubMed ID: 25797219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).
    Parks C; Peipert JF
    Am J Obstet Gynecol; 2016 Jun; 214(6):681-8. PubMed ID: 26875950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
    Davis SA; Braykov NP; Lathrop E; Haddad LB
    J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
    Kavanaugh ML; Jerman J; Finer LB
    Obstet Gynecol; 2015 Nov; 126(5):917-927. PubMed ID: 26444110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.
    Farah D; Andrade TRM; Di Bella ZIKJ; Girão MJBC; Fonseca MCM
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):492-501. PubMed ID: 33140990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
    Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
    Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Moniz MH; Chang T; Heisler M; Admon L; Gebremariam A; Dalton VK; Davis MM
    Obstet Gynecol; 2017 Jun; 129(6):1078-1085. PubMed ID: 28486357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
    Broecker J; Jurich J; Fuchs R
    Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
    Secura GM; Allsworth JE; Madden T; Mullersman JL; Peipert JF
    Am J Obstet Gynecol; 2010 Aug; 203(2):115.e1-7. PubMed ID: 20541171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.